Subscribe to our Newsletters !!

    Roche news

    Swiss drugmaker Roche says interest for Covid-19 tests surpasses production

    Swiss drugmaker Roche can’t fulfill need for sub-atomic tests to distinguish dynamic COVID-19 diseases, its director revealed to Swiss every day Tagesanzeiger. “The interest surpasses our creation,” Christoph Franz was cited as saying in Saturday’s paper. The choice on where tests were sent to depended, in addition to other things, on contamination rates and the

    Roche and GenMark Diagnostics signs Definitive Merger Agreement

    Roche, Basel, Switzerland, and GenMark Diagnostics, Carlsbad, Calif, have entered into a definitive merger agreement for Roche to completely acquire GenMark at a price of $24.05 per share in an all-cash trade. This corresponds to a total transaction value of approximately $1.8 billion on a fully diluted basis. The merger agreement has been unanimously approved